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IntroduCtIon
Peripheral arterial disease (PAD) affects 
approximately 20% of patients aged 
≥60 years.1 A GP with an average list size 
of 1800 patients can expect to have 50–60 
patients with PAD. Ankle-brachial pressure 
index (ABPI), which is the ratio of the ankle 
to brachial systolic pressure measured 
by sphygmomanometer and hand-held 
Doppler ultrasound probe, is used to assess 
PAD in general practice. ABPI has been 
shown to have a sensitivity of 95% and 
specificity of 99% compared to angiographic 
imaging,2 however it is relatively time-
consuming and requires adequately trained 
staff. There are limitations with ABPI in 
patients with diabetes, renal disease, and 
older people where an underestimation 
of disease can occur with a falsely high 
ratio due to the presence of incompressible 
calcified blood vessels.
dIAGnoStIC CHALLEnGES
The characteristic clinical diagnostic 
feature of PAD is intermittent claudication 
(IC), muscle pain brought on by exercise, 
relieved by rest and experienced in the 
calf with femoropopliteal disease and in 
the buttock, hip or thigh with aortoiliac 
disease. However it is sometimes difficult to 
distinguish clinically between claudication 
and leg pain from other causes such as 
spinal stenosis. 
ABPI methodology
The first problem we face is that a significant 
proportion of patients in general practice who 
are arteriopaths are asymptomatic and ABPI 
has been routinely adopted to confirm and 
quantify the diagnosis of peripheral vascular 
disease in those with IC. Unfortunately the 
exact methodology is not standardised, 
beginning with a choice of three arteries 
in the ankle each with potentially differing 
pressures and some of which are commonly 
congenitally absent. Similarly the clinician 
has a choice of two arms for the brachial 
pressure and there is no consensus on 
how the central reference pressure should 
be assessed. Indeed, arteriosclerosis is 
a systemic disease. Failure to lie supine 
can introduce a hydrostatic pressure 
difference between arm and leg. A number 
of environmental factors such as ambient 
temperature can also affect peripheral 
vasomotor tone. The occlusive cuff method 
itself has been called into question with a 
likely underestimate of true pressure drop 
varying with site of lesion and which may be 
exacerbated with baseline hypotension or 
hypertension confounding ABPI readings. 
Finally, there is no consensus on normal 
ranges for ABPI ratios, and hence referral 
thresholds, evidenced by its absence in the 
most recent National Institute for Health and 
Care Excellence guidance.3
Limitations of ABPI
As well as methodological limitations 
and despite the claimed 95% sensitivity 
and 99% specificity, there are a number 
of problematic assumptions. Many of the 
studies of ABPI have used control subjects 
that are clinically asymptomatic volunteers 
rather than angiographically proven 
normals. A rich collateral vessel network 
may be responsible for a proportion of 
asymptomatic PAD patients and ABPI would 
fail to unmask this cohort. Heavy arterial 
calcification resulting in incompressible 
arteries in diabetic, renal, and older patients 
renders the ABPI non-diagnostic. This is 
also problematic in rarer conditions such as 
systemic sclerosis and rheumatic diseases. 
There is a need for a non-invasive alternative 
to ABPI for assessing peripheral vascular 
disease in general practice.
PHotoPLEtHySMoGrAPHy
Photoplethysmography (PPG) is offering a 
new look at diagnosis and management 
of PAD in general practice. PPG is a low 
cost, non-invasive, simple-to-use, and 
fast- to-perform optical technique based 
on peripheral pulse waveform analysis and 
has been shown to have good sensitivity 
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Clinical Question
Can peripheral arterial disease 
be accurately diagnosed in 
general practice?
and specificity for PAD when compared to 
ABPI.4 However the place of this technology 
in general practice is yet to be established.
Methodology and challenges 
PPG typically uses near-infrared (or red) 
light to measure the changes in tissue blood 
volume associated with each heartbeat.5 In 
its simplest form a light source is directed 
towards the tissue microvascular bed, for 
example to the ear lobe, finger, or toe pad, 
and an adjacent photodetector measures 
the small changes in light absorption to 
form a PPG pulse waveform (Figure 1). 
Although the exact nature of PPG is not 
fully understood its signatures in health and 
vascular disease have been described and 
reviewed by Allen.5
The waveforms from PPG technology are 
typically pulsatile and can be compared 
between sites such as the toes and fingers. 
In PAD a damping effect is produced with 
a reduction in amplitude and changes in 
waveform shape and timing compared to a 
healthy vascular bed. 
A simpler variant of PPG, pulse oximetry, 
has already been successfully deployed in 
general practice. The next stage in the 
development of this technology is in its 
routine use for PAD patients in general 
practice.
WHAt It MEAnS For GEnErAL 
PrACtICE
The key determinant to the successful 
embedding of advanced PPG technology 
in general practice is the ability to produce 
clear results indicating significant or 
non-significant disease and for it to be 
reliably delivered by a range of primary 
care professionals. The purpose of such 
technology will be:
• to identify a cohort of patients in whom 
there is no significant PAD and who can 
be reassured; 
• to identify a cohort of patients in whom 
there is significant PAD and make onward 
referral for further evaluation and/or 
intervention; and
• to identify a cohort of patients with mild 
PAD where primary care management is 
indicated (Box 1). 
PAD is a window on widespread 
atherosclerotic cardiovascular disease6 
and advanced PPG technology may give 
opportunities for cardiovascular screening 
in the future. 
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Box 1. Summary of PAd 
management and annual 
monitoring in general practice 
• Assessment of symptoms
• Ankle-brachial pressure index (ABPI)  
  estimation
• Smoking cessation advice
• Cholesterol lowering
• Blood pressure management
• Weight management and exercise
• HBA1c estimation
• Anti-platelet treatment
Figure 1. Photoplethysmography.
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